Vascular Endothelial Growth Factor in Systemic Capillary Leak Syndrome - 12/08/11
Doi : 10.1016/j.amjmed.2009.01.020
Willem Joost Lesterhuis, MD a, b, Alexander J. Rennings, MD h, William P. Leenders, PhD c, Arjan Nooteboom, PhD d, Cornelis J. Punt, MD, PhD b, Fred C. Sweep, PhD e, Peter Pickkers, MD f, Anneke Geurts-Moespot, MSc f, Hanneke W. Van Laarhoven, MD, PhD a, b, Johan Van der Vlag, PhD g, Jo H. Berden, MD, PhD g, Cor T. Postma, MD, Phd a, Jos W. Van der Meer, MD, PhD a, ⁎ 
a Department of General Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
b Department of Medical Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
c Department of Pathology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
d Department of Pediatric Oncology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
e Department of Chemical Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
f Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
g Department of Nephrology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
h Department of Pharmacology-Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Requests for reprints should be addressed to Jos W. Van der Meer, MD, PhD, Department of General Internal Medicine/463, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands
Le texte complet de cet article est disponible en PDF.
| Funding: The academic departments. Bevacizumab was provided without charge by Roche. |
|
| Conflict of Interest: Dr Punt declares that he has received fees as a member of the advisory board of Roche, manufacturer of bevacizumab. None of the other authors have any conflicts of interest associated with the work presented in this manuscript. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
© 2009
Elsevier Inc. Tous droits réservés.
Vol 122 - N° 6
P. e5-e7 - juin 2009 Retour au numéro
Article précédent
- Masquerade: Fulminant Viral Myocarditis Mimicking a Q-wave Anterolateral Myocardial Infarction
- Jonathan R. Dalzell, Colette E. Jackson, Roy S. Gardner
- In Bariatric Surgery, Less Might Be More: Let's Let the Patient Decide
- Simon Lavotshkin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?